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An Aminocaprolactam Racemase from Ochrobactrum anthropi 
with Promiscuous Amino Acid Ester Racemase Activity 
Amina Frese,[a] Sarah V. Barrass, [a] Peter W. Sutton,[b] Joe P. Adams[b] and Gideon Grogan*[a] 
 
Abstract: The kinetic resolution of amino acid esters (AAEs) is a 
useful synthetic strategy for the preparation of single enantiomer 
amino acids.  The development of an enzymatic dynamic kinetic 
resolution (DKR) process for AAEs, which would give a theoretical 
yield of 100% of the enantiopure product, would require an amino 
acid ester racemase (AAER), however, no such enzyme has been 
described.  We have identified low AAER activity of 15 U mg-1 in a 
homolog of a PLP-dependent D-amino H-caprolactam racemase 
(ACLR) from Ochrobactrum anthropi. We have determined the 
structure of this enzyme, OaACLR, to a resolution of 1.87 Å and 
using structure-guided saturation mutagenesis, in combination with a 
colorimetric screen for AAER activity, we have identified a mutant, 
L293C, in which the promiscuous AAER activity of this enzyme 
towards L-phenylalanine methyl ester is improved 3.7 fold. 
 
 
The preparation of enantiopure amino acids is a process of 
significant industrial interest.  While the preparation of naturally 
occurring amino acids is often achieved through fermentation,[1-4] 
other approaches are necessary to provide non-natural products in 
enantiomerically pure form.  Given the excellent selectivity of 
enzymes, it is no surprise that these have emerged as favoured 
catalysts for some of these processes.  The generation of 
enantiopure amino acids has been achieved for many years through 
the kinetic resolution of N-acylated amino acids[5,6] amino acid esters 
(AAEs)[7] or indeed N-acylated AAEs,[8] using hydrolases, although 
the maximum possible yield of these reactions is only 50%.  A 
significant amount of research has therefore been directed towards 
dynamic kinetic resolution (DKR) processes for the quantitative 
formation of enantiopure amino acids.  In these reactions, the 
residual enantiomer following resolution is racemised in situ, 
generating further amounts of the enzymatically-favoured substrate 
enantiomer for hydrolysis.  In addition to abiotic methods of 
racemisation that employ catalysts containing iridium and ruthenium 
[9,10]
 enzymes can also be used for this step.[11]  In one example, an 
N-acyl amino acid racemase (NAAAR) from Amycolatopsis sp. Ts-1±
60 has been applied to the dynamic kinetic resolution of N-acyl 
amino acids including N-acetyl±D/L-allyl glycine 1 (Scheme 1A).[12-15]  
In vitro evolution was used to create a mutant G219D/F323Y of 
improved activity that could be applied in a 50 g L-1 scale resolution 
of the substrate in combination with an enantiospecific acylase.[15] 
The activity of this racemase is dependent on two lysine residues 
acting as proton donor and acceptor and a magnesium ion that 
coordinates the carboxylate of the amino acid substrate. 
 
Scheme 1. A: deracemisation of N-acyl allylglycine using N-acyl amino acid 
racemase (NAAAR) and a D-acylase;[15] B: Racemisation of D-amino H-
caprolactam by D-amino H-caprolactam racemase (HACLR);[18] C:  
Deracemisation of L-alanine amide by HACLR and a D-amino peptidase;[20] D: 
proposed deracemisation RIDPLQRDFLGHVWHUVXVLQJDFRPELQDWLRQRIµDPLQR
DFLGHVWHUUDFHPDVH¶$$(5DQGDQHQDQWLRVHOHFWLYHHVWHUDVHWKLVVWXG\ 
 
In contrast to NAAAR, many other racemases with activity towards 
amino acid derivatives are dependent on the cofactor pyridoxal-¶-
phosphate (PLP).[16,17]  Some of these enzymes have also been 
applied to DKRs.  D-Amino H-caprolactam racemase (ACLR, 
Scheme 1B[18]) from Achromobacter obae, which naturally catalyses 
the racemisation of the H-ACL substrate 3, has been used for the 
industrial production of L-lysine.[19,20] Asano and co-workers 
demonstrated that ACLR also displays promiscuous activity towards 
amino acid amide (AAA) substrates such as alanine amide 4, and 
norvaline and phenylalanine amide[21,22] and have applied the 
enzyme, and a mutant with improved activity,[23] in combination with 
a D-aminopeptidase from Ochrobactrum anthropi, for the dynamic 
kinetic resolution of AAAs (Scheme 1C) to yield D-phenylalanine 
and its derivatives with yields of >99% and enantiomeric excesses 
from 16-99% e.e.  The structure of ACLR was determined[24] and 
used in conjunction with previous solution studies[25] to formulate a 
proposal for the mechanism of the enzyme.  We have recently 
refined the mechanistic hypothesis for ACLR enzymes using high-
resolution crystallographic snapshots of the reaction coordinate with 
the ACLR from Rhizobium frerei (RfACLR).[26]  These studies hint at 
significant ligand dynamics during the racemisation of H-ACL, and 
suggest that Asp210 and Lys267 act as the proton donor/acceptor in 
the racemisation mechanism. 
 
In an extension to the DKR technology, Wegman and co-workers[27] 
demonstrated that, by taking advantage of the faster rate of amino 
acid ester (AAE) racemisation compared to the amide, enantiopure 
amides can be prepared directly from racemic acid esters by lipase 
catalysed ammoniolysis in the presence of aldehydes such as 
pyridoxal. However, aldehydes such as pyridoxal are expensive and 
not readily recycled. Therefore, given the commercial importance of 
amide bond formation from unnatural amino acids and their 
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GHULYDWLYHVZHHQYLVDJHGWKDWWKHGHYHORSPHQWRIµDPLQRDFLGHVWHU
racemases¶ AAERs) could be highly valuable, and that such an 
enzyme may be discovered through an examination of the catalytic 
promiscuity of ACLRs. Catalytic promiscuity of enzymes is a topic of 
significant contemporary interest,[28,29] as the identification of even 
low activity can lead to improved catalysts through protein 
engineering techniques such as directed evolution.  In this report we 
demonstrate low native activity of an ACLR homolog from 
Ochrobactrum anthropi (OaACLR) for AAE racemisation, and the 
structure guided engineering of the enzyme, which has given a 
variant, L293C, displaying higher activity for the racemisation of L-
phenylalanine methyl ester. 
 
Target Selection 
In an effort to identify an enzyme competent for the racemisation of 
amino acid esters, we cloned and expressed three ACLR homologs 
(AoACLR, RfACLR and OaACLR).  RfACLR and OaACLR (Uniprot 
code Q06K28) were identified as putative ACLRs by sequence 
homology search using AoACLR as a model (Details of cloning, 
expression and purification can be found in the Supporting 
Information).  We have examined the ACLR activity of RfACLR 
extensively in a previous study, and used it as a structural target to 
examine ACLR mechanism in general.[26]  OaACLR shares 53 and 
52% sequence identity with AoACLR[18] and RfACLR[26] respectively 
(Figure S1DQGZDVDQQRWDWHGDVDQµDPLQRDFLGDPLGHUDFHPDVH
ZLWKWUDQVDPLQDVHDFWLYLW\¶OaACLR had previously been identified 
as an ACLR by Boesten and co-workers in a patent by DSM[30] and 
also by Asano and co-workers as part of a wider study of ACLR 
homologs in 2015,[31] although was not purified in the latter case. An 
additional ACLR from Ochrobactrum anthropi, Oant_4493, had also 
been identified as having ACLR activity towards D-ACL of 1225 U 
mg-1 by Asano and co-workers,[31] although OaACLR is a different 
enzyme, containing, among other differences, an alanine residue in 
place of a tryptophan in position 49 (AoACLR numbering) of the 
sequence (Figure S1). Otherwise all three enzymes share 
significant homology throughout the length of the polypeptide chain. 
We tested AoACLR, RfACLR and OaACLR for racemisation activity 
towards Damino-H-caprolactam 3, phenylalanine amide 8 and 
phenylalanine methyl ester 9 (Scheme 2) using an HPLC assay 
(Details of HPLC assay can be found in the Supporting 
Information).   
  
Scheme 2. Substrates used in this study: L-3 ± H-ACL; L-8 ± L-Phenylalanine 
amide; L-9 = L-Phenylalanine methyl ester. 
AoACLR and RfACLR showed similar activity towards H-ACL and 
phenylalanine amide. OaACLR displayed approximately ten and 
four-fold reduced specific activity compared to RfACLR for the 
racemisation of H-ACL and phenylalanine amide respectively.  
However, OaACLR also displayed activity towards the ester 
substrate 3 (15.3 U mg-1; Table 1), whereas AoACLR and RfACLR 
did not.   
 
. 
 
Table 1. Comparison of specific activity of OaACLR and RfACLR towards L-H-
ACL 3, L-phenylalanine amide 8 and L-phenylalanine methyl ester 9. 
 Specific activity toward Substrate (U mg-1) 
Enzyme L-3 L-8 L-9 
AoACLR 30117 ± 972 11.9 ± 5.2 0 
RfACLR 26469 ± 5425 20.4 ± 0.8 0 
OaACLR 2337 ± 291 5.2 ± 1.6 15.3 ± 0.7 
 
This difference prompted us to examine differences between these 
ACLRs using X-ray crystallography, in order to identify residues that 
might explain the difference in reactivity and suggest target residues 
for engineering improved amino acid ester racemase activity in 
OaACLR. 
 
Structure of OaACLR 
We crystallised OaACLR and determined the structure of the 
enzyme in complex with PLP to a resolution of 1.87 Å (Details of 
Crystallisation and Table S1 featuring Data Collection and 
Refinement statistics can be found in the Supporting Information).   
The structure featured four molecules in the asymmetric unit, 
constituting two dimers, with two active sites at the dimer interface 
containing PLP (Figure 1A).  There was clear continuous density 
extending from the side chain of Lys267 to the PLP molecule in all 
active sites, indicative of formation of the internal aldimine complex.  
Although co-crystallisation was carried out with different ligands (L-
ACL 3, L-PheNH2 8, L-PheOMe 9, and L-Phenylalanine) under 
numerous conditions, additional ligand density proved insufficient for 
modelling and refinement for any of these compounds. Due to the 
high sequence homology between ACLRs (Figure S1), the overall 
structure of the OaACLR monomer, as well as the structure of the 
active site, is highly conserved with respect to the published 
monomer structures of AoACLR (2ZUK[24]) and RfACLR (e.g. 5M49 
[26]), with rmsds of 0.89 Å and 0.84 Å over 415 C-D atoms 
respectively.   
Conserved residues in addition to Lys267 included Lys241, 
implicated in substrate carbonyl recognition in RfACLR, and Asp210, 
which, with Lys267 are thought to be the proton donors/acceptors in 
the racemase mechanism.  Trp436 at the C-terminus of each 
sequence, which appears to form a gate over the active site in 
RfACLR, is conserved but does not feature in the electron density for 
the OaACLR structure.  Indeed density for this residue in the 
RfACLR structures only featured when ligand was present.[26] Tyr139, 
which stacks against the plane of the H-ACL substrate is conserved, 
but Trp49, which in AoACLR and RfACLR stacks against the other 
face of the substrate, is replaced by Ala51 in OaACLR, creating 
more room in the active site.  Additionally, (B)Met293 from the 
neighbouring monomer in both AoACLR and RfACLR enzymes, 
which is situated beneath the H-ACL ligand at the base of the binding 
pocket, is replaced by Leu293 in OaACLR.  These mutations are 
also to be found, although not together, in other ACLR homologs 
recently expressed by Asano and co-workers.[31]  The differences in 
OaACLR, coupled with its distinctive AAER activity, immediately 
suggested sites for mutation that would both investigate the 
distinctive ability of OaACLR to catalyse the amino acid ester 
racemisation reaction, but also for saturation mutagenesis that may 
improve the promiscuous activity.  
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Figure 1.  A: Structure of OaACLR dimer with subunits shown in ribbon format in light blue and green.  PLP is shown in cylinder format, with carbon atoms in grey, 
in two active sites at the dimer interface; B: Superimposition of active site residue side-chains of RfACLR internal aldimine complex with H-ACL (PDB code 
5M49,[26]) and OaACLR-PLP complex with carbon atoms in coral and green respectively. PLP atoms are shown in grey and the H-ACL carbon atoms from 5M49 in 
yellow. 
A screen for AAAE activity 
In order to embark on in vitro evolution studies of even 
conservatively-sized libraries, it was necessary to develop a plate-
based colorimetric screen for AAER activity. This was based upon 
the assay developed for NAAAR evolution devised by Campopiano 
and co-workers.[15]  In this assay, D-phenylalanine methyl ester (D-
PheOMe D-9) was used as the substrate and racemised by variants 
of OaACLR. In the next step, only L-PheOMe L-9, which is the result 
of AAAE activity, was hydrolysed by an L-alcalase from Bacillus 
licheniformis[32] to L-phenylalanine (L-Phe).  The concentration of L-
Phe could then be determined spectrophotometrically through the 
action of an L-amino acid oxidase (L-AAO), coupled to the 
horseradish peroxidase catalysed transformation of o-dianisidine, 
dependent upon the hydrogen peroxide released in the L-AAO 
reaction (Scheme S1). 
 
Identification and characterisation of the L293C mutant 
Saturation mutagenesis libraries at positions 51 and 293 were 
generated using inverse PCR-based mutagenesis methods using 
NNK degenerate primers. Two libraries, each of 96 mutants, were 
screened using the assay described. Upon comparing the activity of 
the wild-type and mutants from the library only one mutant in 
position 293 could be identified with a significant increase in specific 
activity for racemisation of L-9. None of the tested mutants of the 
library in position 51 gave improved activity over the wild-type. The 
improved mutant was identified as OaACLR-L293C and purified (as 
described in the Supporting Information). Interestingly, the 
purification yield of OaACLR-L293C was improved 1.7-fold over that 
of the wild-type enzyme (5 mg L-1 compared to 3 mg L-1). The activity 
of the purified OaACLR-L293C was determined for L-9 using the 
HPLC assay described. Kinetic parameters were determined by 
measuring the racemisation activity at concentrations up to 60 mM of 
L-9. The Km values recorded for the wild-type and OaACLR-L293C 
were 2.8 mM and 5.6 mM respectively and the Vmax values were 
0.05 µM s-1 and 0.34 µM s-1 (Figure 2). The catalytic efficiency  
 
(kcat/Km) was increased 3.7 fold for the OaACLR-L293C mutant 
compared to the wild-type enzyme, from 0.007 PM-1 s-1 to 0.026 PM-1 
s-1.  In addition, the OaACLR-L293C mutant was less susceptible to 
inhibition, with only 15% loss of activity observed at the highest 
tested substrate concentration, versus 63 % loss of activity for wild-
type OaACLR. Although the reason for the improved activity of the 
Leucine-Cysteine mutant is not clear, it is not attributable to the 
introduction of an alternate acid-base into the active site, as a 
L293C/D210A mutant was shown to be inactive (data not shown). 
 
 
 
 
Figure 2.  Specific activity of OaACLR WT (Ŷ) and L293C mutant (Ƈ) 
measured at increasing concentrations of L-PheOMe (L-9). 
 
Conclusion 
 
The structural diversity of desired amino acid products in industry 
dictates that complementary processes must be sought for the 
generation of these compounds in single enantiomer form.  The 
description of an amino acid esterase activity in this report opens up 
COMMUNICATION          
For internal use, please do not delete. Submitted_Manuscript 
 
 
new possibilities for the identification of similar activities in homologs 
and mutants for other amino acid substrates, with the goals of 
incorporation into preparative dynamic kinetic resolution processes 
for the production of pharmaceutical intermediates. 
Supporting Information 
Amino acid sequences, PCR primers, gene cloning, mutation, 
expression and protein purification protocols; biotransformations, 
HPLC analysis and plate screen development; Protein 
crystallisation, data collection and refinement. 
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